SCHEMBL21997466

SCHEMBL21997466

CN(C(=O)OCc1ccccc1)C1CCC2(C[CH]C2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.50
CCR5 P51681 1/20 0.45
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ENPP2 Q13822 1/20 0.40
CHRM5 P08912 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ABCB1 P08183 1/20 0.40
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
RORC P51449 2/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
DRD1 P21728 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15751249 0.91 SIGMAR1 (0.53) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL21998108 0.86 SIGMAR1 (0.49) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL31734241 0.86 SIGMAR1 (0.49) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL21997212 0.86 SIGMAR1 (0.49) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL22835656 0.85 SIGMAR1 (0.48) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL26351438 0.85 SIGMAR1 (0.48) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL21997413 0.85 SIGMAR1 (0.48) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL1058888 0.85 SIGMAR1 (0.60) SIGMAR1CCR5ALDH1A1MAPK1L3MBTL1
SCHEMBL27866758 0.84 SIGMAR1 (0.51) SIGMAR1CCR5ALDH1A1ENPP2CHRM5
SCHEMBL21997646 0.83 SIGMAR1 (0.47) SIGMAR1CCR5ALDH1A1ENPP2CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3886904-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2021-10-06 EP disclosed
WO-2020113233-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-06-04 WO disclosed